statistiche ricercatore

RIVA, NICOLETTA

Distribuzione geografica

Continente	#
NA - Nord America	2.176
EU - Europa	847
AS - Asia	724
SA - Sud America	68
Continente sconosciuto - Info sul continente non disponibili	51
AF - Africa	12
OC - Oceania	4
Totale	3.882

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.146
IT - Italia	455
SG - Singapore	215
CN - Cina	172
UA - Ucraina	105
VN - Vietnam	99
TR - Turchia	95
HK - Hong Kong	85
SE - Svezia	54
BR - Brasile	53
DE - Germania	44
IE - Irlanda	40
GB - Regno Unito	36
FR - Francia	35
RU - Federazione Russa	29
BD - Bangladesh	22
CA - Canada	18
FI - Finlandia	16
AR - Argentina	8
IN - India	8
MX - Messico	8
HR - Croazia	7
NL - Olanda	6
PL - Polonia	6
PK - Pakistan	5
AU - Australia	4
AT - Austria	3
EG - Egitto	3
IQ - Iraq	3
JP - Giappone	3
PH - Filippine	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
CL - Cile	2
EC - Ecuador	2
ID - Indonesia	2
LT - Lituania	2
MY - Malesia	2
NG - Nigeria	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
AL - Albania	1
BE - Belgio	1
BO - Bolivia	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ES - Italia	1
ET - Etiopia	1
GR - Grecia	1
GT - Guatemala	1
IL - Israele	1
JM - Giamaica	1
LB - Libano	1
LY - Libia	1
MA - Marocco	1
MD - Moldavia	1
OM - Oman	1
PA - Panama	1
RO - Romania	1
SV - El Salvador	1
TH - Thailandia	1
VE - Venezuela	1
Totale	3.831

Salva come PNG Salva come JPEG

Città	#
Milan	329
Fairfield	236
Woodbridge	201
Ashburn	176
San Jose	149
Ann Arbor	142
Houston	134
Singapore	128
Dallas	115
Chandler	96
Cambridge	90
Wilmington	90
Jacksonville	88
Seattle	87
Hong Kong	83
The Dalles	51
Izmir	48
Beijing	40
Princeton	40
Council Bluffs	36
Dublin	36
Ho Chi Minh City	30
Dearborn	29
Boardman	26
Nyköping	26
Lauterbourg	22
Rome	19
Chicago	18
London	16
Los Angeles	16
Dong Ket	15
Hanoi	15
New York	15
Santa Clara	15
Washington	12
Guangzhou	10
San Diego	10
Shanghai	10
Ogden	8
Como	7
Mexico City	7
Zagreb	7
Hefei	6
Montreal	6
Nuremberg	6
Tianjin	6
Warsaw	6
Boston	5
Düsseldorf	5
Hangzhou	5
Toronto	5
Chennai	4
Denver	4
Frankfurt am Main	4
Naples	4
Norwalk	4
Shenzhen	4
Dhaka	3
Haiphong	3
Jinan	3
Nanchang	3
Nanjing	3
Orem	3
Redwood City	3
San Mateo	3
Shibin al Kawm	3
São Paulo	3
Abuja	2
Atlanta	2
Belfast	2
Berlin	2
Besana In Brianza	2
Biên Hòa	2
Brooklyn	2
Campinas	2
Cavaria con Premezzo	2
Changsha	2
Columbus	2
Dalian	2
Elk Grove Village	2
Helsinki	2
Lahore	2
Martinengo	2
Ottawa	2
Panama City	2
Portal	2
Prescot	2
Quzhou	2
Quận Năm	2
San Francisco	2
Santa Fe	2
Stockholm	2
Strasbourg	2
São José do Rio Preto	2
Tashkent	2
Tokyo	2
Trecate	2
Verona	2
Addis Ababa	1
Al Hillah	1
Totale	2.896

Salva come PNG Salva come JPEG

Nome	#
Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes	313
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	260
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data	220
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	216
Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulants	216
Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study	211
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	210
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation	202
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	193
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	184
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.	164
Portal vein thrombosis in decompensated cirrhosis: rationale for treatment	156
Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism	155
Which patients with venous thromboembolism should receive non-vitamin k antagonist oral anticoagulants? The majority	142
Stroke: Patients with CVT urgently need high-quality evidence	125
Clinical history of cancer-associated splanchnic vein thrombosis	113
Recommendations from the ICM-VTE: General	106
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.	101
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score	94
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants	89
Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: A systematic review and meta-analysis	83
Mitigating Disputes Originated by Multiple Discordant Systematic Reviews and Meta-Analyses: A Survey of Methodologists and Clinicians	81
Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected pulmonary embolism: a systematic review and meta-analysis	75
The effect of DOAC-Stop® on several oral and parenteral anticoagulants	70
Trials of interventions for ovarian and testicular germ cell tumors registered in ClinicalTrials.gov: A cross-sectional study	52
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis	51
Totale	3.882

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	16.777
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	16.777

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	144	0	9	4	2	7	12	6	9	4	50	17	24
2022/2023	257	21	8	28	18	21	54	3	41	40	9	4	10
2023/2024	559	90	90	80	106	118	51	0	2	10	9	0	3
2024/2025	384	3	3	56	12	17	46	26	18	19	52	45	87
2025/2026	969	74	61	108	94	72	61	216	59	88	71	40	25
2026/2027	60	29	31	0	0	0	0	0	0	0	0	0	0
Totale													3.882